Therapeutic compounds
US7799821B2 · kind B2 · utility
1Cited by
11References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2006 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Dec 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC50 value of 20 nM or less at the prostaglandin EP2 receptor according to the cAMP assay.Methods, compositions, and medicaments related thereto are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.